
Director appointments at Hanover
pharmafile | January 22, 2014 | Appointment | Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Hanover, harrison
Comms and PR consulting firm Hanover has announced senior management changes within its healthcare practice.
Andrew Harrison (pictured) takes on a new role of director of Global Healthcare, focussing on delivering international pharma and healthcare campaigns.
He will work closely with Hanover’s London and Brussels offices, and the company’s wider global network.
Dr Mark Saxon becomes director of UK Healthcare, taking responsibility for the 16-strong team. Saxon will focus on continuing firm’s attention on pharma brand communications and market access.
Hanover’s clients include Lilly, MSD, UCB, Amgen, private hospital group HCA, and a number of organisations within the NHS.
Harrison said: “The new roles reflect this growth and build on a number of European programmes we are currently delivering for clients. They will enable us to better meet our clients’, and our own, ambitions for the future.”
Harrison will continue to work on a small number of key UK client accounts.






